#efta00506148
LightNews LightNews
epsteinweb.bsky.social
EFTA00506148.jpg
#epsteinweb #efta00506148
https://epsteinweb.org
Available in the iOS app store now!
https://apps.apple.com/us/app/epstein-web/id6758880661
EFTA00506107 | EFTA00506148 ConcentRx Investment Thesis • Poised to quickly file IND with unprecedented preclinical data in an area of high unmet medical need - ovarian cancer. ▪ Both components of the dual biotherapy (CIK cells, vaccinia virus) have been extensively vetted by the scientific and regulatory community, and have both been FDA approved for human therapy. ▪ Platform technology play in autologous cell-based immune therapy ▪ • • production of therapy for other partners in the space joint development deals with companies seeking to develop autologous therapies • own product portfolio Scientific and managemetR-t team has a proven track record. DAC ART C_ API JAL LLC: EFTA00506148
May 3, 2026 at 2:19 AM